CRVS
Corvus Pharmaceuticals Inc
11.80$
-5.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 63.7% | 61.4% | 57.0% | 74.7% | 73.0% | 79.0% | 76.5% | 84.7% | 83.2% | 81.9% | 94.8% | 92.3% | |
| 38.7% | 27.7% | 18.6% | 23.0% | 8.0% | 12.7% | 8.4% | 16.4% | 3.6% | 6.4% | 15.8% | 7.9% | |
| 61.9% | 59.6% | 55.2% | 73.2% | 70.8% | 75.4% | 74.4% | 83.2% | 81.6% | 79.8% | 93.5% | 90.0% | |
| 0.1% | 0.1% | 0.1% | 0.2% | 0.4% | 0.3% | 0.4% | 0.3% | 0.4% | 0.5% | 0.5% | 0.8% | |
| 1.3% | – | 56.9% | – | – | – | – | – | – | – | – | – | |
| 14.7% | 15.1% | 16.8% | 20.7% | 78.9% | 52.7% | 17.0% | 10.3% | 10.8% | 13.9% | 4.9% | 5.8% | |
| 14.1% | 15.1% | 16.8% | 20.7% | 78.9% | 51.4% | 15.6% | 9.5% | 10.0% | 13.2% | 4.8% | 5.7% | |
| 2.6% | 3.0% | 2.6% | 1.1% | 0.6% | 0.3% | 0.5% | 0.4% | 0.5% | 0.6% | 0.2% | 0.2% | |
| 2.7% | 3.3% | 4.0% | 1.9% | 3.2% | 3.7% | 2.2% | 3.5% | 2.5% | 3.5% | 1.9% | 1.7% | |
| 85.3% | 84.9% | 83.2% | 79.3% | 21.1% | 47.3% | 83.0% | 89.7% | 89.2% | 86.1% | 95.1% | 94.2% | |
| -631.6% | -734.8% | -849.3% | -533.9% | -654.4% | -576.2% | -642.4% | -435.7% | -497.0% | -579.7% | -168.2% | -185.5% | |
| 94.3% | 107.7% | 122.3% | 92.5% | 113.4% | 99.2% | 126.4% | 86.9% | 102.9% | 112.1% | 35.5% | 38.6% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.